thalidomide has been researched along with prednisolone in 116 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (8.62) | 18.7374 |
| 1990's | 6 (5.17) | 18.2507 |
| 2000's | 36 (31.03) | 29.6817 |
| 2010's | 58 (50.00) | 24.3611 |
| 2020's | 6 (5.17) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jolliffe, DS | 1 |
| Gilkes, JJ; Robinson, TW; Rustin, MH | 1 |
| Waters, MF | 1 |
| Gajl-Peczalska, KJ; Good, RA; Jacobson, RR; Lim, SD | 1 |
| Cazort, RJ | 1 |
| Coulson, AS | 1 |
| Errigo, E; Guidetti, E; Martelli, MP; Moiraghi-Ruggenini, A | 1 |
| Nelson, DS; Nelson, M; Pearson, JM; Thurston, JM; Waters, MF | 1 |
| Chaudhry, AP; Schmutz, JA | 1 |
| Civier, A; Hensby, CN; Maloubier, A; Ortonne, JP; Shroot, B | 1 |
| Joseph, M; Rajagopalan, MS; Rajan, MA | 1 |
| Naafs, B | 1 |
| Grabczyska, SA; Hawk, JL | 1 |
| Black, MM; Bracka, A; Bunker, CB; Farrell, AM | 1 |
| Kampmeier, JK; Kaven, CK; Lang, GE; Lang, GK; Spraul, CW | 1 |
| Kinsey, SE; Pratt, G | 1 |
| Achenbach, A; Bohmeyer, J; Stadler, R; Westenberger, M | 1 |
| Fruehauf, S; Goldschmidt, H; Hartschuh, W; Ho, AD; Moehler, T; Neben, K; Witzens, M | 1 |
| Aikawa, S; Hatta, Y; Horie, T; Ito, T; Kanbe, E; Kitamura, K; Kura, Y; Oka, H; Saiki, M; Sawada, U; Takeuchi, J; Yamazaki, T | 1 |
| Ganapati, R; Pai, VV | 1 |
| Dimopoulos, MA; Rahemtulla, A; Terpos, E | 1 |
| Brouwers, JR; Duyvendak, M; Kingma, BJ; Naunton, M | 1 |
| Hansen, M; Hansen, PB | 1 |
| Kunihiko, M; Mariko, Y; Shinichiro, O; Yasuo, I; Yusuke, T; Yutaka, H | 1 |
| Kumar, S | 1 |
| Mahajan, VK; Sarin, S; Sharma, NL; Sharma, RC; Sharma, VC | 1 |
| Czyzewski, K; Styczynski, J; Wysocki, M | 1 |
| Cantelli, S; Catizone, L; Fabbian, F; Molino, C; Russo, G; Russo, M; Sartori, S; Stabellini, N | 1 |
| Okamoto, S | 1 |
| Hoyer, RJ; Lacy, MQ; Leung, N; Witzig, TE | 1 |
| Iida, S | 2 |
| McLean, C; Patil, S; Schwarer, A | 1 |
| Kamezaki, K; Nagafuji, K | 1 |
| Ishida, T | 1 |
| Okamoto, S; Tomita, S | 1 |
| Bilic, S; Copeman, M; Cremers, S; Kennedy, N; Lynch, K; Neeman, T; Ravera, C; Roberts, A; Schran, H; Spencer, A | 1 |
| Curtin, NJ; Harrison, CN; McMullin, MF; Radia, D; Reilly, JT; Weinkove, R | 1 |
| Kawamura, N; Kira, J | 1 |
| Boldt, T; Goldschmidt, H; Haas, A; Hoffmann, FA; Kreibich, U; Niederwieser, D; Pönisch, W; Ritter, U; Rohrberg, R; Rozanski, M; Schirmer, V; Schwalbe, E; Schwarzer, A; Uhlig, J; Zehrfeld, T | 1 |
| Adam, Z; Drach, J; Egyed, M; Gisslinger, H; Greil, R; Hajek, R; Hinke, A; Kuhn, I; Labar, B; Ludwig, H; Spicka, I; Tóthová, E; Zojer, N | 1 |
| Anderson, AM; Bhattarai, B; Brandsma, JW; Faber, WR; Feuth, M; Feuth, T | 1 |
| Higa, GM; Saad, AA; Sharma, M | 1 |
| Bradstock, KF; Coyle, L; Gill, DS; Horvath, N; Kennedy, N; Prince, HM; Prosser, IW; Reynolds, J; Roberts, AW; Spencer, A | 1 |
| Lockwood, DN; Ramirez, J; Richardus, JH; van Brakel, WH; Van Veen, NH | 2 |
| De, D; Dogra, S; Kaur, I; Narang, T | 1 |
| Brioli, A; Cavo, M; Pallotti, MC; Pantani, L; Petrucci, A; Tacchetti, P; Tosi, P; Zamagni, E | 1 |
| García-Sanz, R; González-López, TJ; Graciani, IF; Hermida, G; San Miguel, JF; Vázquez, L | 1 |
| Kanda, Y | 1 |
| Ozaki, S | 1 |
| Kim, TH; Myung, SC; Oh, SY | 1 |
| Chung, JS; Do, YR; Eom, HS; Jin, JY; Kim, CS; Kim, HJ; Kim, HY; Kim, K; Kim, YK; Lee, DS; Lee, JH; Oh, SJ; Seong, CM; Suh, C | 1 |
| Hogan, WJ; Hussein, K; Litzow, MR; Mesa, RA; Pardanani, AD; Schwager, S; Tefferi, A; Wu, W | 1 |
| Fleming, A; Goldsmith, P; Jankowski, J | 1 |
| Chalmers, RJ; Reddick, CL; Singh, MN | 1 |
| Boyd, KD; Chiecchio, L; Davies, FE; Morgan, GJ; Neri, A; Ross, FM; Smith, EM; Walker, BA; Wardell, CP | 1 |
| Du, W; Hattori, Y; Jinzaki, M; Miyakawa, Y; Okamoto, S; Shinmoto, H; Yamada, T; Yokoyama, K | 1 |
| Allegra, A; Alonci, A; Catena, S; D'Angelo, A; Gerace, D; Greve, B; Musolino, C; Penna, G; Russo, S | 1 |
| Sucak, GT; Suyanı, E; Yağcı, M | 1 |
| Allegra, A; Alonci, A; Cannavò, A; D'Angelo, A; Musolino, C; Penna, G; Petrungaro, A; Romeo, G; Russo, S | 1 |
| Chai, F; Malik, P | 1 |
| Brown, RD; Daniher, D; Gibson, J; Ho, PJ; Jeffels, M; Joshua, DE; Spencer, A | 1 |
| Balducci, M; Chiusolo, P; De Stefano, V; Giannotta, C; Laurenti, L; Leone, G; Luigetti, M; Sabatelli, M; Sica, S; Sorà, F; Vannata, B | 1 |
| Guo, S; Zhao, J | 1 |
| Kaczmarczyk-Sedlak, I; Rotko, K; Sedlak, L; Zych, M | 1 |
| Gonçalves, R; Lopes, J; Macedo, G; Sobrinho Simões, M; Vilas-Boas, F | 1 |
| Ambaliya, A; Dosi, RV; Joshi, HJ; Patell, RD | 1 |
| Choi, KH; Kim, BS; Lee, SK; Lee, SW; Park, KH; Park, YB; Yang, J | 1 |
| Bajwah, S; Higginson, IJ; Koffman, J; Patel, AS; Peacock, JL; Riley, J; Ross, JR; Wells, AU | 1 |
| Attarian, H; Ghadyani, M; Haghighi, S; Rezvani, H | 1 |
| Suzuki, K | 1 |
| Hisa, S; Kanno, Y; Kobayashi, A; Mizukami, H; Nakazato, K; Noji, H; Ogawa, K; Ohkawara, H; Saitoh, S; Shichishima-Nakamura, A; Suzuki, H; Takahashi, H; Takeishi, Y; Yokokawa, T; Yoshihisa, A | 1 |
| Aoki, K; Arima, H; Imai, H; Ishikawa, T; Kato, A; Matsushita, A; Mori, M; Nagano, S; Ono, Y; Tabata, S; Takahashi, T; Takiuchi, Y; Yanagita, S | 1 |
| Al-Ali, HK; Beck, J; Edelmann, T; Hebenstreit, K; Heyn, S; Hoffmann, FA; Jäkel, N; Lange, T; Mohren, M; Niederwieser, D; Pönisch, W; Röhrborn, R; Schmalfeld, M; Schwarzer, A; Wagner, I; Winkelmann, C; Zehrfeld, T | 1 |
| Bryant, J; Clegg, A; Cooper, K; Picot, J | 1 |
| Brain, T; Khalafallah, A; Mohamed, M | 1 |
| Fuchida, S; Hino, M; Ishii, K; Kanakura, Y; Kaneko, H; Kobayashi, M; Kosugi, S; Kuroda, J; Matsumura, I; Nomura, S; Ohta, K; Shibayama, H; Shimazaki, C; Shimura, Y; Takaori-Kondo, A; Tanaka, H; Taniwaki, M; Tsudo, M; Uoshima, N | 1 |
| Chen, CY; Chen, YC; Chou, SJ; Chou, WC; Hou, HA; Huang, SY; Lin, CW; Lin, HH; Lu, HY; Tang, JL; Tien, HF; Tsay, W; Wu, SJ; Yao, M | 1 |
| Caballero, D; Coiffier, B; d'Amore, F; Dearden, C; Federico, M; Gomes da Silva, M; Jäger, U; Morschhauser, F; Pettengell, R; Tilly, H; Trümper, L; Weidmann, E; Zinzani, PL; Zucca, E | 1 |
| Yamamoto, K | 1 |
| Akasaka, H; Ito, K; Kodaka, T; Sakane, E; Takahashi, T; Tsunemine, H; Yoshioka, S | 1 |
| Ganesan, V; Mandal, J | 1 |
| Rahul, N; Sanjay, KS; Singh, S | 1 |
| Cao, J; Chang, J; Guo, Y; Hong, X; Ji, D; Li, Q; Liu, X; Luo, Z; Lv, F; Wang, B; Wang, L; Wu, X | 1 |
| Jain, N; Malhotra, P; Prakash, G; Sahu, KK; Saikia, U; Yanamandra, U | 1 |
| Ahn, JS; Cho, MS; Choi, HJ; Hwang, EC; Jung, SH; Jung, TY; Kim, HJ; Kim, YK; Lee, JJ; Lee, SS; Shin, MG; Yang, DH | 1 |
| Benner, A; Blau, IW; Döhner, H; Döhner, K; Gattermann, N; Grießhammer, M; Hebart, H; Heidel, FH; Hochhaus, A; Jost, E; Kreipe, H; Platzbecker, U; Reiter, A; Schafhausen, P; Schlenk, RF; Stegelmann, F; Teleanu, V; Verbeek, W; Waller, C; Werner, M | 1 |
| Rabinovich, CE; Schanberg, LE; Wershba, EC; Wu, EY | 1 |
| Choi, YS; Eom, HS; Han, JJ; Kang, HJ; Kim, HJ; Kim, K; Kim, MK; Kim, SH; Kwon, J; Lee, JH; Lee, JJ; Lee, JO; Lee, WS; Min, CK; Moon, JH; Yoon, DH; Yoon, SS | 1 |
| Fuchida, SI; Hatsuse, M; Murakami, S; Odaira, E; Okano, A; Shimazaki, C | 1 |
| Bakane, A; Balaji, R; Raj, R; Ramachandrakurup, S; Subburaj, D; Uppuluri, R | 1 |
| Chang, Y; Duan, W; Fu, X; Li, L; Li, X; Li, Z; Nan, F; Sun, Z; Wang, X; Wu, J; Yan, J; Young, KH; Zhang, L; Zhang, M; Zhang, X | 1 |
| Andrea, M; Beck, J; Becker, C; Bill, M; Edelmann, T; Gläser, D; Heyn, S; Hoffmann, FA; Jentzsch, M; Kragl, B; Kreibich, U; Lange, T; Mohren, M; Mügge, LO; Niederwieser, D; Pönisch, W; Schliwa, T; Schwarzer, A; Schwind, S; Uhlig, J; Winkelmann, C; Zehrfeld, T | 1 |
| Fang, L; Hu, N; Huang, G; Li, B; Luo, X; Pan, L; Peter Gale, R; Qin, T; Qu, S; Xiao, Z; Xu, Z; Zhang, H; Zhang, P; Zhang, Y | 1 |
| Minkov, M | 1 |
| Gupta, L; Kar, HK | 1 |
| Lu, S; Ouyang, W; Wang, Z; Zhao, X | 1 |
| Hashimoto, H; Hoashi, T; Ichiyama, S; Kanda, N; Matsushita, M; Nozawa, K; Saeki, H; Ueno, T | 1 |
| Auger-Quittet, S; Bareau, B; Belhadj-Merzoug, K; Benboubker, L; Bosson, JL; Boyle, E; Cliquennois, M; Decaux, O; Fuzibet, JG; Karlin, L; Leleu, X; Leyronnas, C; Orsini-Piocelle, F; Pegourie, B; Pernod, G; Rey, P; Rodon, P; Royer, B; Slama, B; Tiab, M; Voog, E; Zarnitsky, C | 1 |
| Geng, H; Jia, E; Jiang, Y; Qiu, X; Wei, J; Xiao, M; Xiao, Y; Xie, J; Zhang, J; Zhang, Y; Zhong, L | 1 |
| Esparza, MAG; García-Chavez, J; Hernandez-Caballero, A; Majluf-Cruz, A; Montiel-Cervantes, LA; Reyes-Maldonado, E; Rodríguez-González, MG; Vela-Ojeda, J | 1 |
| Nair, M; Nair, SS; Poyuran, R; Vysakha, KV | 1 |
| Doki, N; Kosugi, H; Meguro, K; Murakami, H; Sasaki, O; Shimizu, K; Sunami, K; Suzuki, K; Takagi, T | 1 |
| Baek, JH; Han, YJ; Im, JH; Kwon, HY; Lee, JS | 1 |
| Cai, K; Hunyor, I; Keech, A; Khandkar, C; McGill, N; Penglase, R; Shin, JS; Vaidya, K | 1 |
| Bradbury, CA; Cairns, DA; Child, JA; Cook, G; Craig, Z; Davies, FE; Drayson, MT; Gregory, WM; Hockaday, A; Jackson, GH; Jenner, MW; Jones, JR; Kaiser, MF; Morgan, GJ; Owen, RG; Paterson, A; Pawlyn, C | 1 |
| Li, J; Wu, Q; Zhou, P | 1 |
| Chen, Y; Cutter, D; Loh, Y; Master, Z; Mikhaeel, G; Nagarajan, C; Thitsar, SM; Tin, KM; Yeoh, KW | 1 |
| Hirahara, L; Kirino, Y; Mizuki, N; Nakajima, H; Soejima, Y; Takase-Minegishi, K; Takeno, M; Takeuchi, M; Yoshimi, R | 1 |
| Ahuja, A; Bathula, S; Khurana, A; Mathachan, SR; Paliwal, P; Sardana, K | 1 |
29 review(s) available for thalidomide and prednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Leprosy reactional states and their treatment.
Topics: Antigen-Antibody Complex; Clofazimine; Dapsone; Humans; Immunity, Cellular; Leprosy; Prednisolone; Thalidomide | 1977 |
Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Clofazimine; Cyclosporine; Drug Administration Schedule; Erythema Nodosum; Humans; Hypersensitivity, Delayed; Immunosuppressive Agents; Leprostatic Agents; Leprosy; Leprosy, Lepromatous; Peripheral Nervous System Diseases; Prednisolone; Prednisone; Thalidomide | 1996 |
Managing PLE and actinic prurigo.
Topics: Acute Disease; Anti-Inflammatory Agents; Humans; Immunosuppressive Agents; Photosensitivity Disorders; Prednisolone; Prurigo; Thalidomide | 1997 |
Pyoderma gangrenosum of the penis.
Topics: Adult; Anti-Inflammatory Agents; Antitrichomonal Agents; Combined Modality Therapy; Drug Therapy, Combination; Erythromycin; Humans; Leprostatic Agents; Male; Metronidazole; Middle Aged; Minocycline; Penile Diseases; Penis; Prednisolone; Pyoderma Gangrenosum; Surgery, Plastic; Thalidomide | 1998 |
Current treatment options for myeloma.
Topics: Age Factors; Algorithms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Boronic Acids; Bortezomib; Combined Modality Therapy; Diphosphonates; Doxorubicin; Humans; Melphalan; Multiple Myeloma; Osteolysis; Prednisolone; Pyrazines; Randomized Controlled Trials as Topic; Recurrence; Stem Cell Transplantation; Survival Analysis; Thalidomide; Transplantation, Autologous; Vincristine | 2005 |
[Recent progress in diagnosis of and therapy for multiple myeloma].
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Melphalan; Multiple Myeloma; Prednisolone; Pyrazines; Thalidomide | 2006 |
[Recent progress in the treatment of multiple myeloma].
Topics: Age Factors; Antineoplastic Agents, Alkylating; Boronic Acids; Bortezomib; Diphosphonates; Drug Design; Football; Humans; Immunosuppressive Agents; Melphalan; Multiple Myeloma; Prednisolone; Pyrazines; Randomized Controlled Trials as Topic; Reference Standards; Thalidomide | 2007 |
[POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Biomarkers; Diagnosis, Differential; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; POEMS Syndrome; Prednisolone; Thalidomide; Vascular Endothelial Growth Factor A | 2007 |
[Chemotherapy for multiple myeloma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Humans; Melphalan; Meta-Analysis as Topic; Multiple Myeloma; Prednisolone; Pulse Therapy, Drug; Pyrazines; Thalidomide; Vincristine | 2007 |
[Role of interferon for the treatment of myeloma].
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Meta-Analysis as Topic; Multiple Myeloma; Polyethylene Glycols; Prednisolone; Recombinant Proteins; Remission Induction; Thalidomide | 2007 |
[Treatment strategy for POEMS syndrome].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Humans; Immunoglobulins; Melphalan; Peripheral Blood Stem Cell Transplantation; Plasma Exchange; POEMS Syndrome; Prednisolone; Prognosis; Radiotherapy; Surgical Procedures, Operative; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A | 2008 |
Treatment of multiple myeloma in the targeted therapy era.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Clinical Trials as Topic; Combined Modality Therapy; Dexamethasone; Drug Delivery Systems; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Melphalan; Multiple Myeloma; Prednisolone; Pyrazines; Salvage Therapy; Thalidomide; Transplantation Conditioning | 2009 |
Interventions for erythema nodosum leprosum.
Topics: Aspirin; Clofazimine; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Prednisolone; Randomized Controlled Trials as Topic; Remission Induction; Thalidomide | 2009 |
[Hematopoietic stem cell transplantation for multiple myeloma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Clinical Trials as Topic; Dexamethasone; Doxorubicin; Drug Discovery; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Interferons; Melphalan; Multiple Myeloma; Prednisolone; Pyrazines; Thalidomide; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Vincristine | 2009 |
[New treatment strategies for multiple myeloma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Clinical Trials, Phase III as Topic; Dexamethasone; Diagnosis, Differential; Doxorubicin; Drug Discovery; Female; Humans; Lenalidomide; Male; Melphalan; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Prednisolone; Pyrazines; Remission Induction; Salvage Therapy; Thalidomide; Vincristine | 2009 |
Interventions for erythema nodosum leprosum. A Cochrane review.
Topics: Aspirin; Clofazimine; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Prednisolone; Randomized Controlled Trials as Topic; Thalidomide; Treatment Outcome | 2009 |
Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lenalidomide; Multiple Myeloma; Prednisolone; Stevens-Johnson Syndrome; Thalidomide | 2012 |
[Multiple myeloma].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Denosumab; Diphosphonates; Humans; Imidazoles; Melphalan; Multiple Myeloma; Peripheral Nervous System Diseases; Prednisolone; Pyrazines; Randomized Controlled Trials as Topic; Thalidomide; Zoledronic Acid | 2012 |
Immunotherapy for tuberculosis: what's the better choice?
Topics: Cytokines; Etanercept; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Immunotherapy; Interferon-gamma; Interleukin-2; Mycobacterium tuberculosis; Prednisolone; Receptors, Tumor Necrosis Factor; Th1 Cells; Th2 Cells; Thalidomide; Tuberculosis Vaccines; Tuberculosis, Pulmonary | 2012 |
Thalidomide-induced acute cholestatic hepatitis: case report and review of the literature.
Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemical and Drug Induced Liver Injury; Darbepoetin alfa; Diazepam; Erythropoietin; Fatal Outcome; Humans; Jaundice, Obstructive; Liver Function Tests; Male; Melphalan; Multiple Myeloma; Omeprazole; Pneumonia; Polypharmacy; Prednisolone; Thalidomide | 2012 |
Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Cough; Dyspnea; Exercise Test; Fibrosis; Glucocorticoids; Heroin; Humans; Immunologic Factors; Lung; Lung Diseases, Interstitial; Narcotics; Oxygen Inhalation Therapy; Piperazines; Prednisolone; Purines; Pyridones; Quality of Life; Sildenafil Citrate; Sulfones; Thalidomide; Tubulin Modulators | 2013 |
Current therapeutic strategy for multiple myeloma.
Topics: Age Factors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Density Conservation Agents; Boronic Acids; Bortezomib; Clinical Trials as Topic; Creatinine; Cyclophosphamide; Denosumab; Dexamethasone; Diphosphonates; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Imidazoles; Immunoglobulins; Kidney; Lenalidomide; Leukemia, Myeloid, Acute; Maintenance Chemotherapy; Melphalan; Molecular Targeted Therapy; Multiple Myeloma; Neoplasms, Second Primary; Precision Medicine; Prednisolone; Pyrazines; Quality of Life; Recurrence; Remission Induction; Survival Rate; Thalidomide; Zoledronic Acid | 2013 |
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cyclophosphamide; Depsipeptides; Diphtheria Toxin; Doxorubicin; Folic Acid Antagonists; Histone Deacetylase Inhibitors; Humans; Immunoconjugates; Interleukin-2; Lenalidomide; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Peptides, Cyclic; Prednisolone; Recombinant Fusion Proteins; Stem Cell Transplantation; Thalidomide; Topoisomerase Inhibitors; Vincristine | 2014 |
[Standard of care and new drugs for diffuse large B-cell lymphoma].
Topics: Adenine; Animals; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Discovery; Epigenesis, Genetic; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Mice; Molecular Targeted Therapy; Piperidines; Prednisolone; Prednisone; Pyrazoles; Pyrimidines; Radiotherapy, Adjuvant; Rituximab; Thalidomide; Vincristine; Vindesine | 2014 |
[Successful treatment of relapsed and refractory multiple myeloma by using clarithromycin-lenalidomide, low-dose dexamethasone(BiRd), and melphalan-prednisolone(MP)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Dexamethasone; Female; Humans; Lenalidomide; Male; Melphalan; Multiple Myeloma; Prednisolone; Recurrence; Thalidomide | 2015 |
Quincke's edema and hypersensitivity pneumonitis induced by lenalidomide for multiple myeloma.
Topics: Alveolitis, Extrinsic Allergic; Angioedema; Angiogenesis Inhibitors; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Prednisolone; Thalidomide; Tomography, X-Ray Computed | 2016 |
An update on the treatment of pediatric-onset Langerhans cell histiocytosis through pharmacotherapy.
Topics: Antineoplastic Agents; Central Nervous System; Child; Clinical Trials as Topic; Drug Therapy, Combination; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Prednisolone; Thalidomide; Vinblastine | 2018 |
Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review.
Topics: Antibodies; Asian People; Cyclosporine; Dermatomyositis; Erythema; Female; Humans; Methotrexate; Middle Aged; Prednisolone; Pruritus; Thalidomide; Treatment Outcome; Ubiquitin-Activating Enzymes | 2019 |
26 trial(s) available for thalidomide and prednisolone
| Article | Year |
|---|---|
An internally-controlled double blind trial of thalidomide in severe erythema nodosum leprosum.
Topics: Adrenocorticotropic Hormone; Adult; Chronic Disease; Clinical Trials as Topic; Erythema Nodosum; Humans; Leprosy; Male; Middle Aged; Prednisolone; Thalidomide | 1971 |
Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Train
Topics: Drug Therapy, Combination; Glucocorticoids; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Prednisolone; Thalidomide; Treatment Outcome | 1996 |
Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Creatinine; Diphosphonates; Female; Humans; Imidazoles; Kidney; Male; Middle Aged; Multiple Myeloma; Prednisolone; Thalidomide; Zoledronic Acid | 2008 |
Low-dose thalidomide in myelofibrosis.
Topics: Aged; Aged, 80 and over; Blood Transfusion; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Primary Myelofibrosis; Spleen; Stem Cell Transplantation; Thalidomide; Transplantation, Homologous; Treatment Outcome | 2008 |
Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Multiple Myeloma; Nitrogen Mustard Compounds; Prednisolone; Recurrence; Statistics, Nonparametric; Stem Cell Transplantation; Survival Rate; Thalidomide; Transplantation, Autologous | 2008 |
Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Dexamethasone; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Multiple Myeloma; Predictive Value of Tests; Prednisolone; Survival Rate; Thalidomide; Treatment Outcome | 2009 |
Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Child; Erythema Nodosum; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Mycobacterium leprae; Nepal; Prednisolone; Severity of Illness Index; Thalidomide; Treatment Outcome; Young Adult | 2008 |
Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Glucocorticoids; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisolone; Stem Cell Transplantation; Survival Analysis; Thalidomide; Transplantation, Autologous | 2009 |
Comparative efficacy of thalidomide and prednisolone in the treatment of moderate to severe erythema nodosum leprosum: a randomized study.
Topics: Administration, Oral; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema Nodosum; Female; Follow-Up Studies; Humans; Leprosy, Lepromatous; Male; Middle Aged; Prednisolone; Probability; Prospective Studies; Recurrence; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Thalidomide; Treatment Outcome | 2009 |
Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multip
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Dexamethasone; Female; Hematopoietic Stem Cell Transplantation; Humans; Korea; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoadjuvant Therapy; Prednisolone; Pyrazines; Thalidomide; Treatment Outcome | 2010 |
Phase1/-2 study of Pomalidomide in myelofibrosis.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Anti-Inflammatory Agents; Female; Humans; Immunosuppressive Agents; Male; Maximum Tolerated Dose; Middle Aged; Prednisolone; Primary Myelofibrosis; Thalidomide | 2010 |
Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cluster Analysis; Cyclophosphamide; Dexamethasone; Disease Progression; DNA Methylation; Doxorubicin; Humans; In Situ Hybridization, Fluorescence; Melphalan; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Precancerous Conditions; Prednisolone; Prognosis; Stem Cell Transplantation; Thalidomide; Vincristine | 2011 |
Prospective study of combination therapy with low-dose thalidomide plus prednisolone ameliorating cytopenia in primary myelofibrosis.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Female; Humans; Middle Aged; Prednisolone; Primary Myelofibrosis; Prospective Studies; Thalidomide | 2011 |
Thalidomide consolidation improves progression-free survival in myeloma with normal but not up-regulated expression of fibroblast growth factor receptor 3: analysis from the Australasian Leukaemia and Lymphoma Group MM6 clinical trial.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 4; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Gene Expression Regulation, Neoplastic; Humans; Multiple Myeloma; Prednisolone; Prognosis; Receptor, Fibroblast Growth Factor, Type 3; Stem Cell Transplantation; Thalidomide; Translocation, Genetic; Transplantation, Autologous; Treatment Outcome; Up-Regulation | 2012 |
Efficacy of taxotere, thalidomide, and prednisolone in patients with hormone-resistant metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Gonadotropin-Releasing Hormone; Humans; Kaplan-Meier Estimate; Male; Prednisolone; Prostate-Specific Antigen; Prostatic Neoplasms; Soft Tissue Neoplasms; Taxoids; Thalidomide | 2012 |
Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Nitrogen Mustard Compounds; Prednisolone; Recurrence; Thalidomide | 2013 |
Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; China; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisolone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Remission Induction; Rituximab; Thalidomide; Time Factors; Treatment Outcome; Vincristine | 2016 |
Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis.
Topics: Aged; Aged, 80 and over; Alleles; Biomarkers; Chromosome Banding; Female; Humans; Immunologic Factors; Male; Middle Aged; Mutation; Myeloproliferative Disorders; Phenotype; Prednisolone; Primary Myelofibrosis; Thalidomide; Treatment Outcome | 2017 |
The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Prednisone; Prospective Studies; RNA, Messenger; RNA, Neoplasm; Survival Analysis; Thalidomide; Treatment Outcome; Vincristine; Young Adult | 2017 |
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Disease-Free Survival; Female; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Prednisolone; Prospective Studies; Thalidomide | 2017 |
Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response.
Topics: Adult; Aged; Anemia; Danazol; Female; Humans; Male; Middle Aged; Prednisolone; Primary Myelofibrosis; Thalidomide | 2018 |
Comparative efficacy of four treatment regimens in Type 2 Leprosy Reactions (Prednisolone alone, Thalidomide alone, Prednisolone plus Thalidomide and Prednisolone plus Clofazimine).
Topics: Adult; Clofazimine; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Longitudinal Studies; Male; Middle Aged; Prednisolone; Prospective Studies; Thalidomide; Treatment Outcome; Young Adult | 2016 |
Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Humans; Lenalidomide; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisolone; Pyrazoles; Pyridones; Thalidomide; Venous Thromboembolism | 2019 |
Post-treatment improvement of NK cell numbers predicts better survival in myeloma patients treated with thalidomide-based regimens.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Disease-Free Survival; Female; Humans; Killer Cells, Natural; Lymphocyte Count; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisolone; Survival Rate; Thalidomide | 2019 |
Report of phase I and II trials of melphalan, prednisolone, and thalidomide triplet combination therapy versus melphalan and prednisolone doublet combination therapy in Japanese patients with newly diagnosed multiple myeloma ineligible for autologous stem
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asian People; Autografts; Double-Blind Method; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisolone; Stem Cell Transplantation; Thalidomide; Treatment Outcome | 2019 |
Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Incidence; Kaplan-Meier Estimate; Lenalidomide; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisolone; Progression-Free Survival; Risk Assessment; Thalidomide; Thrombophilia; Thrombosis; Transplantation, Autologous; Venous Thromboembolism; Vincristine | 2020 |
61 other study(ies) available for thalidomide and prednisolone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Pyoderma gangrenosum associated with Behçet's disease: treatment with thalidomide.
Topics: Adult; Behcet Syndrome; Gangrene; Humans; Leg Ulcer; Male; Prednisolone; Pyoderma; Recurrence; Thalidomide | 1990 |
B lymphocytes in lepromatous leprosy.
Topics: Adult; Aged; B-Lymphocytes; Dapsone; Fluorescent Antibody Technique; Humans; Immune Sera; Immunoglobulin A; Immunoglobulin E; Immunoglobulin G; Immunoglobulin M; Leprosy; Leukocyte Count; Middle Aged; Prednisolone; Thalidomide | 1973 |
A trial of thalidomide in progressive lepra reactions.
Topics: Female; Humans; Leprosy; Male; Prednisolone; Thalidomide | 1966 |
Recognition pathway in lymphocytes.
Topics: Animals; Antigen-Antibody Reactions; Antigens; Antilymphocyte Serum; Binding Sites; Cell Membrane; Immunoglobulin G; In Vitro Techniques; Lectins; Lymphocyte Activation; Lymphocytes; Prednisolone; Rabbits; Testosterone; Thalidomide | 1969 |
[Immunodepressive action of thalidomide and prednisolone in rats with experimentally induced neoplasms].
Topics: Animals; Complement Fixation Tests; Immunosuppressive Agents; Prednisolone; Rats; Sarcoma, Yoshida; Thalidomide | 1969 |
Phytohaemagglutinin-induced lymphocyte transformation in leprosy.
Topics: Asian People; Biopsy; China; Erythema Nodosum; Humans; India; Lectins; Leprosy; Lymphocyte Activation; Lymphocytes; Malaysia; Nasopharyngeal Neoplasms; Prednisolone; Thalidomide | 1971 |
Effects of prednisolone and thalidomide on induced submandibular gland tumors in hamsters.
Topics: Animals; Benz(a)Anthracenes; Cricetinae; Fibrosarcoma; Neoplasms, Experimental; Prednisolone; Salivary Gland Neoplasms; Submandibular Gland; Thalidomide | 1966 |
A model for studying the anti-prostaglandin activity of drugs in human skin.
Topics: Adult; Aged; Arachidonic Acids; Dapsone; Furans; Humans; Indomethacin; Male; Middle Aged; Nicotinic Acids; Piperazines; Prednisolone; Prostaglandin Antagonists; Prostaglandins; Skin; Thalidomide | 1984 |
A clinical study of thalidomide comparing pre-treatment and post-treatment reactional episodes and corticosteroid requirements.
Topics: Adolescent; Drug Therapy, Combination; Erythema Nodosum; Humans; Leprosy; Male; Prednisolone; Thalidomide; Time Factors | 1983 |
Effect of thalidomide, octreotide, and prednisolone on the migration and proliferation of RPE cells in vitro.
Topics: Animals; Cattle; Cell Division; Cell Movement; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Octreotide; Pigment Epithelium of Eye; Prednisolone; Thalidomide | 1999 |
Remission of severe, intractable autoimmune haemolytic anaemia following matched unrelated donor transplantation.
Topics: Adrenal Cortex Hormones; Alemtuzumab; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Blood Transfusion; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Depletion; Male; Prednisolone; Remission Induction; Thalidomide; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2001 |
[Thalidomide therapy of cutaneous lupus erythematosus].
Topics: Adult; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Intradermal Tests; Lupus Erythematosus, Cutaneous; Middle Aged; Patch Tests; Prednisolone; Thalidomide | 2002 |
Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide.
Topics: Adjuvants, Immunologic; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Humans; Idarubicin; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Thalidomide; Vasculitis, Leukocytoclastic, Cutaneous; Vincristine | 2004 |
[Multiple myeloma of the IgD-lambda type invading CNS].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Immunoglobulin D; Injections, Spinal; Interferon-alpha; Melphalan; Meningeal Neoplasms; Methotrexate; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplasm Invasiveness; Nitrosourea Compounds; Prednisolone; Radiotherapy, Adjuvant; Thalidomide; Vincristine | 2004 |
Reactions and their management.
Topics: Arthritis; Cicatrix; Clofazimine; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Edema; Erythema; Erythema Nodosum; Foot; Glucocorticoids; Hand; Humans; Hypersensitivity; Immunosuppressive Agents; Leprosy; Lymphadenitis; Neuritis; Paralysis; Prednisolone; Skin; Thalidomide; Treatment Outcome | 2004 |
Thalidomide-associated thrombocytopenia.
Topics: Administration, Oral; Aged; Dexamethasone; Female; Humans; Melphalan; Multiple Myeloma; Neutropenia; Prednisolone; Thalidomide; Thrombocytopenia; Treatment Outcome | 2005 |
[Refractory anaemia successfully treated with thalidomide].
Topics: Anemia, Refractory; Angiogenesis Inhibitors; Drug Therapy, Combination; Hemoglobins; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Thalidomide; Treatment Outcome | 2006 |
Thalidomide for the treatment of leptomeningeal multiple myeloma.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Immunoglobulin G; Melphalan; Meningeal Neoplasms; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Prednisolone; Prednisone; Thalidomide; Vindesine | 2006 |
Progress in the treatment of multiple myeloma.
Topics: Aged; Antineoplastic Agents, Alkylating; Disease-Free Survival; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Melphalan; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Prednisolone; Randomized Controlled Trials as Topic; Thalidomide | 2006 |
Erythema nodosum leprosum and HIV infection: A therapeutic experience.
Topics: Adult; Anti-HIV Agents; Colchicine; Erythema Nodosum; HIV Infections; Humans; Ibuprofen; Leprostatic Agents; Leprosy, Lepromatous; Male; Prednisolone; Thalidomide | 2005 |
Ex vivo activity of thalidomide in childhood acute leukemia.
Topics: Angiogenesis Inhibitors; Cell Cycle; Child; Child, Preschool; Cytarabine; Female; Humans; Immunophenotyping; Infant; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tetrazolium Salts; Thalidomide; Thiazoles | 2006 |
Role of B-type natriuretic peptide in cardiovascular state monitoring in a hemodialysis patient with primary amyloidosis.
Topics: Amyloidosis; Anti-Inflammatory Agents; Bicarbonates; Buffers; Cardiac Output, Low; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Melphalan; Middle Aged; Natriuretic Peptide, Brain; Nephrotic Syndrome; Prednisolone; Renal Dialysis; Thalidomide; Treatment Outcome | 2006 |
Treatment of diuretic refractory pleural effusions with bevacizumab in four patients with primary systemic amyloidosis.
Topics: Amyloidosis; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Captopril; Chest Tubes; Combined Modality Therapy; Dexamethasone; Diuretics; Drug Resistance; Edema; Fatal Outcome; Furosemide; Humans; Hypoalbuminemia; Male; Melphalan; Metolazone; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Peripheral Blood Stem Cell Transplantation; Pleural Effusion; Prednisolone; Serum Albumin; Spironolactone; Thalidomide; Thoracostomy; Transplantation, Autologous; Vascular Endothelial Growth Factor A | 2007 |
Urinary cytology in multiple myeloma.
Topics: Acute Kidney Injury; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Fatal Outcome; Humans; Kidney Neoplasms; Male; Melphalan; Multiple Myeloma; Paraproteinemias; Plasma Cells; Plasmacytoma; Prednisolone; Thalidomide; Urine | 2008 |
Thalidomide maintenance in multiple myeloma: certainties and controversies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Glucocorticoids; Humans; Melphalan; Multiple Myeloma; Prednisolone; Stem Cell Transplantation; Survival Analysis; Thalidomide; Transplantation, Autologous | 2009 |
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Organoplatinum Compounds; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Thalidomide; Topotecan; Transplantation, Autologous; Vidarabine; Vinblastine; Vincristine | 2010 |
Pyoderma gangranosum of the penis.
Topics: Anti-Inflammatory Agents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Penile Diseases; Penis; Prednisolone; Pyoderma Gangrenosum; Thalidomide; Treatment Outcome | 2009 |
In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: a feasibility study.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Embryo, Nonmammalian; Feasibility Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Larva; Mesalamine; Prednisolone; Sesquiterpenes; Thalidomide; Zebrafish | 2010 |
Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Comorbidity; Cyclosporine; Dapsone; Hidradenitis Suppurativa; Humans; Infliximab; Male; Methylprednisolone; Middle Aged; Minocycline; Prednisolone; Pyoderma Gangrenosum; Thalidomide; Treatment Outcome | 2010 |
Complete remission with a combination of lenalidomide, cyclophosphamide and prednisolone in a patient with incomplete POEMS syndrome.
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Gait Disorders, Neurologic; Glucocorticoids; Hand Deformities, Acquired; Humans; Lenalidomide; POEMS Syndrome; Prednisolone; Proteasome Inhibitors; Remission Induction; Thalidomide; Vascular Endothelial Growth Factors | 2011 |
Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Antineoplastic Agents; Dexamethasone; Drug Eruptions; Female; HLA-A Antigens; HLA-B Antigens; HLA-C Antigens; HLA-DQ beta-Chains; HLA-DRB1 Chains; Humans; Italy; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Prednisolone; Severity of Illness Index; Thalidomide; White People | 2012 |
AL amyloidosis in a patient with macroglossia.
Topics: Aged; Amyloidosis; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunoglobulin kappa-Chains; Macroglossia; Magnetic Resonance Imaging; Melphalan; Prednisolone; Risk Assessment; Severity of Illness Index; Thalidomide; Treatment Outcome | 2011 |
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Humans; Humerus; Immunologic Factors; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Osteosclerosis; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Prednisolone; Recurrence; Salvage Therapy; Thalidomide; Transplantation, Autologous | 2012 |
Effects of thalidomide on the development of bone damage caused by prednisolone in rats.
Topics: Administration, Oral; Animals; Bone Remodeling; Dose-Response Relationship, Drug; Femur; Glucocorticoids; Immunologic Factors; Lumbar Vertebrae; Male; Organ Size; Osteoporosis; Prednisolone; Rats; Rats, Wistar; Thalidomide; Tibia; Weight Gain | 2012 |
A rare case of plasma cell leukemia in a 35 year old.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Humans; Leukemia, Plasma Cell; Male; Melphalan; Prednisolone; Thalidomide | 2010 |
Attenuation of nephritis in lupus-prone mice by thalidomide.
Topics: Animals; Anti-Inflammatory Agents; Antigen-Antibody Complex; DNA; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glomerulonephritis; Immunoglobulin G; Immunosuppressive Agents; Lupus Nephritis; Mice; Mice, Inbred NZB; Mycophenolic Acid; Prednisolone; Proteinuria; Survival Rate; Thalidomide | 2012 |
Pulmonary hypertension and refractory heart failure in a patient with Crow-Fukase (POEMS) syndrome.
Topics: Aged; Dexamethasone; Diuretics; Drug Resistance; Edema; Furosemide; Heart Failure; Humans; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Male; Melphalan; POEMS Syndrome; Polysomnography; Prednisolone; Pulmonary Wedge Pressure; Sleep Apnea Syndromes; Thalidomide; Ultrasonography; Vascular Endothelial Growth Factor A; Ventricular Dysfunction, Left | 2013 |
Therapeutic effects of lenalidomide on hemorrhagic intestinal myeloma-associated AL amyloidosis.
Topics: Aged; Amyloid; Amyloidosis; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bone Diseases; Boronic Acids; Bortezomib; Carpal Tunnel Syndrome; Dexamethasone; Disease Progression; Doxorubicin; Duodenal Diseases; Female; Femur Head; Fractures, Spontaneous; Gastrointestinal Hemorrhage; Hip Fractures; Humans; Jejunal Diseases; Lenalidomide; Melphalan; Multiple Myeloma; Osteolysis; Prednisolone; Pyrazines; Thalidomide; Vincristine | 2013 |
Comparative cost-effectiveness models for the treatment of multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cost-Benefit Analysis; Disease Progression; Humans; Melphalan; Models, Economic; Multiple Myeloma; Prednisolone; Pyrazines; Survival Analysis; Thalidomide; United Kingdom | 2014 |
Dramatic response of diffuse osteosclerosis secondary to multiple myeloma using thalidomide with melphalan and prednisolone.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Melphalan; Multiple Myeloma; Osteosclerosis; Prednisolone; Thalidomide | 2014 |
Limited value of the international staging system for predicting long-term outcome of transplant-ineligible, newly diagnosed, symptomatic multiple myeloma in the era of novel agents.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Female; Humans; Lenalidomide; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Staging; Prednisolone; Prognosis; Pyrazines; Retreatment; Salvage Therapy; Thalidomide; Treatment Outcome | 2014 |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma.
Topics: Adaptor Proteins, Signal Transducing; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Boronic Acids; Bortezomib; Dexamethasone; Female; Follow-Up Studies; Gene Expression Profiling; Humans; Lenalidomide; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Proteins; Neoplastic Stem Cells; Paraffin Embedding; Peptide Hydrolases; Prednisolone; Pyrazines; Salvage Therapy; Survival Analysis; Syndecan-1; Thalidomide; Treatment Outcome; Ubiquitin-Protein Ligases | 2014 |
Primary oral tuberculosis in a patient with lepromatous leprosy: Diagnostic dilemma.
Topics: Anti-Inflammatory Agents; Clofazimine; Coinfection; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Middle Aged; Mouth Mucosa; Mycobacterium tuberculosis; Prednisolone; Thalidomide; Tongue; Tuberculosis, Oral | 2016 |
Effectiveness of Methotrexate in prednisolone and thalidomide resistant cases of Type 2 lepra reaction: report on three cases.
Topics: Adult; Drug Resistance, Bacterial; Humans; Leprosy; Male; Methotrexate; Mycobacterium lepraemurium; Prednisolone; Thalidomide; Treatment Outcome | 2015 |
Plasmablastic lymphoma: successful management with CHOP and lenalidomide in resource constraint settings.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lenalidomide; Lymphoma, AIDS-Related; Maxillary Sinus Neoplasms; Plasmablastic Lymphoma; Poverty; Prednisolone; Remission Induction; Thalidomide; Vincristine | 2016 |
Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression.
Topics: Adaptor Proteins, Signal Transducing; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bortezomib; Cyclophosphamide; Dexamethasone; Female; Follow-Up Studies; Gene Expression; Humans; Immunologic Factors; Kaplan-Meier Estimate; Male; Melphalan; Multiple Myeloma; Neoplasm Proteins; Peptide Hydrolases; Prednisolone; Remission Induction; Survival Analysis; Thalidomide; Treatment Outcome; Ubiquitin-Protein Ligases | 2016 |
Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus.
Topics: Adolescent; Female; Humans; Immunologic Factors; Lenalidomide; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Prednisolone; Retrospective Studies; Thalidomide; Treatment Outcome; Young Adult | 2017 |
Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Prednisolone; Retrospective Studies; Survival Analysis; Thalidomide; Treatment Outcome | 2017 |
Successful Treatment of Refractory Langerhans Cell Histiocytosis of the Choroid Plexus in a Child With Pulse Dexamethasone and Lenalidomide.
Topics: Choroid Plexus; Cladribine; Cytarabine; Dexamethasone; Diabetes Insipidus; Drug Resistance; Histiocytosis, Langerhans-Cell; Humans; Infant; Lenalidomide; Male; Pituitary Gland, Posterior; Prednisolone; Pulse Therapy, Drug; Remission Induction; Salvage Therapy; Skull Base; Thalidomide; Thoracic Vertebrae; Vinblastine | 2017 |
Prevalence of monoclonal gammopathy of uncertain significance in chronic myeloid leukemia: A case report.
Topics: Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Mutation; Positive Regulatory Domain I-Binding Factor 1; Prednisolone; Prevalence; Thalidomide; Treatment Outcome | 2018 |
Psoriasis vulgaris associated with systemic lupus erythematosus successfully treated with apremilast.
Topics: Administration, Oral; Adult; Antibodies, Antinuclear; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Systemic; Phosphodiesterase 4 Inhibitors; Prednisolone; Psoriasis; Severity of Illness Index; Thalidomide; Treatment Outcome | 2019 |
An unusual presentation of scleromyxedema as inflammatory myopathy.
Topics: Adult; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Myositis; Prednisolone; Scleromyxedema; Thalidomide | 2019 |
Two cases of immune reconstitution inflammatory syndrome in HIV patients treated with thalidomide.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Brain Edema; Dose-Response Relationship, Drug; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Immunosuppressive Agents; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Prednisolone; Thalidomide; Treatment Outcome | 2019 |
Rare case of infiltrative cardiomyopathy secondary to scleromyxoedema.
Topics: Adult; Cardiomyopathies; Female; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Prednisolone; Rare Diseases; Scleromyxedema; Thalidomide | 2020 |
Vocal cord involvement and hoarseness in a patient with Behcets disease: A rare case report.
Topics: Adult; Behcet Syndrome; Drug Therapy, Combination; Female; Glucocorticoids; Hoarseness; Humans; Immunosuppressive Agents; Laryngoscopy; Pharyngitis; Prednisolone; Thalidomide; Treatment Outcome; Vocal Cords | 2020 |
Pleural plasmacytomas - the role of radiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Fatal Outcome; Female; Humans; Lenalidomide; Melphalan; Multiple Myeloma; Pleural Neoplasms; Prednisolone; Thalidomide | 2020 |
Efficacy and safety of apremilast for 3 months in Behçet's disease: A prospective observational study.
Topics: Adult; Behcet Syndrome; Colchicine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Oral Ulcer; Prednisolone; Prospective Studies; Thalidomide; Tumor Necrosis Factor-alpha | 2021 |
A real-world study of low-dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource-constrained target population.
Topics: Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Leprosy, Multibacillary; Panniculitis; Prednisolone; Thalidomide; Vascular Diseases | 2023 |